Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats
about
Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitorsPathological and protective roles of glia in chronic painThe "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting gliaChemotherapy-induced peripheral neurotoxicity and complementary and alternative medicines: progress and perspectiveMechanisms involved in the development of chemotherapy-induced neuropathySpinal interleukin-10 therapy to treat peripheral neuropathic painMechanisms of chemotherapy-induced behavioral toxicitiesEmerging Relationships between Exercise, Sensory Nerves, and Neuropathic PainBortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouseIL-10 mediated by herpes simplex virus vector reduces neuropathic pain induced by HIV gp120 combined with ddC in ratsPolyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert PanelDesign, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisPEGylation of interleukin-10 for the mitigation of enhanced pain states.Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain.CXCR1/2 pathways in paclitaxel-induced neuropathic painIntravenous Administration of Substance P Attenuates Mechanical Allodynia Following Nerve Injury by Regulating Neuropathic Pain-Related Factors.Bilateral changes of TNF-alpha and IL-10 protein in the lumbar and cervical dorsal root ganglia following a unilateral chronic constriction injury of the sciatic nerveImprovement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain.Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Monocytes/Macrophages control resolution of transient inflammatory pain.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Pain-related mediators underlie incision-induced mechanical nociception in the dorsal root ganglia.IL-4 deficiency is associated with mechanical hypersensitivity in mice.Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.Gyejigachulbu-Tang Relieves Oxaliplatin-Induced Neuropathic Cold and Mechanical Hypersensitivity in Rats via the Suppression of Spinal Glial Activation.Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes.Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.Systemic inflammation decreases pain threshold in humans in vivo.Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injuryEstrogen alters baseline and inflammatory-induced cytokine levels independent from hypothalamic-pituitary-adrenal axis activityCannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice.Divergent cerebrospinal fluid cytokine network induced by non-viral and different viral infections on the central nervous system.PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of NeuropathySensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy.Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathyPrevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.MAPK signaling downstream to TLR4 contributes to paclitaxel-induced peripheral neuropathy.New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.
P2860
Q21203940-7FFFD782-A96A-44AF-93F9-7777F40761CBQ24646738-7F83ACF3-F111-4DC3-BEE3-FB0DE94385D4Q24650739-3D841BFE-3C15-4F4D-AB26-14C3C8F1590FQ26777967-7ABB98CF-F591-471D-A9AB-E69FFBB8D509Q26824380-9D881ADC-ED0C-4500-A2F0-1AD7BF1DD939Q26861391-A71A896B-3E2A-477B-B538-4D4CA0FA55E0Q26998870-A3BC7EDC-6D0A-4C3A-B17C-01D6AC8AA645Q28066195-1C4871B1-AFAF-401F-BC8D-900FC7B97A50Q28533426-69ECCCC3-496E-4879-B07B-6E82A56B5A2BQ28577054-9D50591F-1716-4F03-B857-4ADCE2163990Q30039702-834128D4-0688-4265-9731-D84BA4BC41ACQ30276131-76816C14-047C-49A2-8077-942EF5DAAE00Q33505369-39C978EA-8FE4-457F-8496-A06F7C7546F7Q33562058-B6917481-ABFE-445B-A749-384E78D9F14CQ33618624-D3B7617A-CD25-4140-9420-C4229A28AF9BQ33655878-0ACF9583-C524-4F12-9992-68E6535C3B7EQ33687631-8C4489E7-AF00-453F-9792-BB829B74EF04Q33713080-DC020BD9-5E78-45C3-B05F-E3956B61E6A0Q33744706-846D908C-D596-495C-BD84-D26EA36D9B80Q33823432-C2FCC70B-AD43-4D3C-8C87-213B4FE0AFAEQ33824948-83FFF08B-BC9B-4C15-B1D9-9541072249DDQ34094673-7EA833C9-E76B-41E3-AE0E-6F9FDF758186Q34099062-07E3034D-3AE7-40D5-A46B-06FE8345D3BBQ34194773-E242AD41-4CF9-4B11-A7C7-A65DCBDF7680Q34579481-638716E5-0711-4271-B8FC-6EFAE34D3673Q34610876-E83E5AC4-0C32-40A1-B39B-DC0D69676E42Q34642112-4E41043C-6746-4D30-B509-B0A3C9D4E009Q34765028-FE4979C5-10B6-4F7D-9E17-1317CA548A79Q35073261-EDD2E590-53FD-406A-BA55-AFDF82C00D2AQ35121911-083D20CF-3D6B-44A4-A71A-21DEC03FA222Q35195146-7243E9FD-8052-49F0-858C-C2EA30F5A966Q35644331-4E042826-922D-4412-BE4E-46719AA1F9C6Q35749605-63B78278-457A-4D0F-9995-123187806644Q35795123-B36AC44B-814B-44E9-946D-C116E11E75E5Q35798221-C6CFB7A3-8A3E-4C08-B984-14B2DB1433FAQ35803293-3BCC43FB-1736-42FA-88C1-49724E4386E3Q35907148-600518EA-C522-4CC1-8460-96D42FAEC2D6Q35928226-4A549538-1D1F-48D1-80CD-F29144CB842CQ36053079-45056180-0F8F-46B2-85E6-51579E06DAB2Q36226275-F09D12B5-A809-4CB3-BDE7-226DC23D24FC
P2860
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Intrathecal interleukin-10 gen ...... in dorsal root ganglia in rats
@en
Intrathecal interleukin-10 gen ...... n dorsal root ganglia in rats.
@nl
type
label
Intrathecal interleukin-10 gen ...... in dorsal root ganglia in rats
@en
Intrathecal interleukin-10 gen ...... n dorsal root ganglia in rats.
@nl
prefLabel
Intrathecal interleukin-10 gen ...... in dorsal root ganglia in rats
@en
Intrathecal interleukin-10 gen ...... n dorsal root ganglia in rats.
@nl
P2093
P2860
P1476
Intrathecal interleukin-10 gen ...... in dorsal root ganglia in rats
@en
P2093
Annemarie Ledeboer
Brian M Jekich
David Martin
Erin D Milligan
Evan M Sloane
John H Mahoney
Kirk W Johnson
Leslie A Leinwand
Raymond A Chavez
Stephen J Langer
P2860
P304
P356
10.1016/J.BBI.2006.10.012
P577
2006-12-15T00:00:00Z